Aeterna Zentaris
AEZS
#10173
Rank
A$24.71 M
Marketcap
A$8.07
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.89. In 2022 the company made an earnings per share (EPS) of A-$6.60 a decrease over its 2021 EPS that were of A-$2.57.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.60157.14%
2021A-$2.57-41.48%
2020A-$4.39-64.46%
2019A-$12.35-240%
2018A$8.82-122.32%
2017A-$39.51-53.53%
2016A-$85.02-86.71%
2015A-$639.98-35.21%
2014A-$987.84-216.67%
2013A$846.72-123.3%
2012A-$3,634-40.8%
2011A-$6,139-6.45%
2010A-$6,562-27.91%
2009A-$9,102-61.61%
2008A-$23,70883.61%
2007A-$12,912-195.31%
2006A$13,547178.26%
2005A$4,869-330%
2004A-$2,117-80.05%
2003A-$10,61017.78%
2002A-$9,009515.93%
2001A-$1,463-68.6%
2000A-$4,659119.62%
1999A-$2,121-3.63%
1998A-$2,201

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.39-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.91-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.19-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$6.90-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA